LEQVIO

inclisiran · Novartis Pharmaceuticals Corporation

Drug timelines are a Plus or Pro feature.

25 regulatory and trial events tracked for LEQVIO, covering 2021-12-22 to 2026-08-19. Get the full timeline:

Most recent: FDA Approved: LEQVIO — Supplemental Application (Novartis Pharmaceuticals Corporation)